A Johns Hopkins Hospital study has demonstrated that during the first four years of the institution’s “bloodless” program, outcomes for bloodless surgical and medical noncardiac populations were either equivalent to or better than those who underwent standard-of-care protocols.
“There has been mounting evidence that shows restrictive allogeneic blood transfusion—defined as a hemoglobin trigger of 7 [g/dL] for transfusion—is associated with equivalent or